Huntington Potter
Concepts (364)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 43 | 2025 | 595 | 7.340 |
Why?
| | Amyloid beta-Peptides | 22 | 2022 | 235 | 3.430 |
Why?
| | Electroporation | 8 | 2018 | 38 | 2.680 |
Why?
| | Transfection | 10 | 2018 | 943 | 2.350 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 5 | 2025 | 160 | 2.020 |
Why?
| | Cognition Disorders | 13 | 2012 | 518 | 2.000 |
Why?
| | Amyloid beta-Protein Precursor | 14 | 2022 | 67 | 1.530 |
Why?
| | Neurons | 7 | 2025 | 1621 | 1.320 |
Why?
| | Cognitive Dysfunction | 6 | 2020 | 412 | 1.310 |
Why?
| | Down Syndrome | 8 | 2024 | 506 | 1.210 |
Why?
| | tau Proteins | 4 | 2019 | 95 | 1.190 |
Why?
| | Aneuploidy | 4 | 2017 | 89 | 1.180 |
Why?
| | Neuropsychological Tests | 14 | 2020 | 1093 | 1.120 |
Why?
| | Cognition | 11 | 2022 | 1228 | 1.040 |
Why?
| | Chromosome Segregation | 3 | 2013 | 47 | 0.960 |
Why?
| | Mice, Transgenic | 19 | 2018 | 2184 | 0.880 |
Why?
| | Apolipoprotein E4 | 3 | 2022 | 38 | 0.840 |
Why?
| | West Nile Fever | 2 | 2023 | 53 | 0.810 |
Why?
| | Apolipoproteins E | 7 | 2019 | 91 | 0.780 |
Why?
| | Spindle Apparatus | 3 | 2013 | 104 | 0.760 |
Why?
| | Immune System | 2 | 2022 | 183 | 0.750 |
Why?
| | Dementia | 6 | 2012 | 263 | 0.740 |
Why?
| | Exosomes | 2 | 2020 | 105 | 0.730 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 153 | 0.720 |
Why?
| | Brain | 14 | 2024 | 2868 | 0.700 |
Why?
| | Peptide Fragments | 6 | 2022 | 701 | 0.690 |
Why?
| | Animals | 40 | 2025 | 37749 | 0.670 |
Why?
| | Caffeine | 4 | 2012 | 74 | 0.670 |
Why?
| | Ultracentrifugation | 1 | 2020 | 52 | 0.660 |
Why?
| | Psychiatric Status Rating Scales | 5 | 2012 | 561 | 0.660 |
Why?
| | Apathy | 1 | 2020 | 8 | 0.660 |
Why?
| | Disease Models, Animal | 16 | 2025 | 4421 | 0.660 |
Why?
| | Temporal Lobe | 6 | 2012 | 105 | 0.640 |
Why?
| | Presenilin-1 | 6 | 2016 | 33 | 0.610 |
Why?
| | Hippocampus | 7 | 2022 | 940 | 0.600 |
Why?
| | Alzheimer Vaccines | 2 | 2008 | 2 | 0.570 |
Why?
| | Mice | 26 | 2023 | 18109 | 0.570 |
Why?
| | Frontotemporal Lobar Degeneration | 1 | 2017 | 18 | 0.550 |
Why?
| | Gene Expression | 5 | 2020 | 1492 | 0.540 |
Why?
| | Central Nervous System Stimulants | 3 | 2009 | 178 | 0.530 |
Why?
| | Aging | 3 | 2025 | 1924 | 0.510 |
Why?
| | Uniparental Disomy | 1 | 2016 | 9 | 0.480 |
Why?
| | Amyloid | 3 | 2021 | 97 | 0.480 |
Why?
| | Islet Amyloid Polypeptide | 3 | 2021 | 48 | 0.480 |
Why?
| | alpha 1-Antichymotrypsin | 2 | 2006 | 4 | 0.480 |
Why?
| | Microtubule-Associated Proteins | 2 | 2015 | 198 | 0.470 |
Why?
| | DNA | 3 | 2018 | 1444 | 0.450 |
Why?
| | Axonal Transport | 1 | 2015 | 26 | 0.450 |
Why?
| | Atrophy | 8 | 2011 | 197 | 0.450 |
Why?
| | Apoptosis | 3 | 2025 | 2576 | 0.450 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 374 | 0.450 |
Why?
| | Trisomy | 1 | 2016 | 79 | 0.450 |
Why?
| | Cells, Cultured | 12 | 2020 | 4212 | 0.450 |
Why?
| | Bacteriophage phi X 174 | 1 | 2014 | 5 | 0.450 |
Why?
| | Plasma | 2 | 2024 | 221 | 0.450 |
Why?
| | Coronavirus Infections | 1 | 2020 | 371 | 0.450 |
Why?
| | Astrocytes | 3 | 2022 | 217 | 0.440 |
Why?
| | Genetic Loci | 3 | 2025 | 277 | 0.440 |
Why?
| | Nanoparticles | 1 | 2020 | 484 | 0.440 |
Why?
| | Humans | 57 | 2025 | 141754 | 0.430 |
Why?
| | Molecular Biology | 1 | 2014 | 60 | 0.430 |
Why?
| | Receptors, Neurotransmitter | 1 | 2014 | 20 | 0.430 |
Why?
| | Maze Learning | 7 | 2010 | 104 | 0.420 |
Why?
| | Protoplasts | 5 | 2018 | 7 | 0.420 |
Why?
| | DNA, Viral | 2 | 2021 | 367 | 0.410 |
Why?
| | Nerve Growth Factors | 1 | 2014 | 79 | 0.410 |
Why?
| | Proteomics | 1 | 2020 | 1138 | 0.410 |
Why?
| | Niemann-Pick Disease, Type C | 1 | 2013 | 2 | 0.400 |
Why?
| | Mitosis | 2 | 2011 | 197 | 0.400 |
Why?
| | Glial Fibrillary Acidic Protein | 2 | 2025 | 112 | 0.400 |
Why?
| | Mutation | 6 | 2017 | 4015 | 0.390 |
Why?
| | DNA Replication | 1 | 2014 | 240 | 0.390 |
Why?
| | Aged | 22 | 2025 | 24746 | 0.380 |
Why?
| | Aged, 80 and over | 14 | 2025 | 7923 | 0.370 |
Why?
| | Cholesterol, LDL | 1 | 2013 | 361 | 0.340 |
Why?
| | Molecular Motor Proteins | 1 | 2011 | 46 | 0.340 |
Why?
| | White Matter | 2 | 2023 | 148 | 0.320 |
Why?
| | Memory, Episodic | 2 | 2021 | 53 | 0.320 |
Why?
| | Chromosomes, Mammalian | 1 | 2009 | 28 | 0.320 |
Why?
| | Receptors, LDL | 1 | 2010 | 52 | 0.320 |
Why?
| | Neuropharmacology | 1 | 2009 | 5 | 0.310 |
Why?
| | Amyloidosis | 1 | 2010 | 49 | 0.310 |
Why?
| | Genetic Predisposition to Disease | 6 | 2025 | 2375 | 0.310 |
Why?
| | Plants | 4 | 2018 | 225 | 0.310 |
Why?
| | Infusion Pumps, Implantable | 1 | 2009 | 26 | 0.310 |
Why?
| | Disease Progression | 6 | 2012 | 2800 | 0.300 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 90 | 0.300 |
Why?
| | Atherosclerosis | 1 | 2013 | 404 | 0.300 |
Why?
| | Checklist | 1 | 2010 | 106 | 0.290 |
Why?
| | Multicenter Studies as Topic | 1 | 2010 | 363 | 0.290 |
Why?
| | Magnetic Resonance Imaging | 9 | 2012 | 3737 | 0.270 |
Why?
| | Encephalitis | 3 | 2020 | 137 | 0.260 |
Why?
| | Herpes Zoster | 2 | 2021 | 319 | 0.250 |
Why?
| | Genome-Wide Association Study | 4 | 2025 | 1406 | 0.250 |
Why?
| | Environment | 3 | 2007 | 342 | 0.240 |
Why?
| | Activities of Daily Living | 1 | 2009 | 427 | 0.240 |
Why?
| | Neurofilament Proteins | 1 | 2025 | 62 | 0.230 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2025 | 60 | 0.230 |
Why?
| | Memory | 2 | 2020 | 263 | 0.230 |
Why?
| | Gliosis | 2 | 2023 | 28 | 0.220 |
Why?
| | Dendritic Cells | 1 | 2008 | 505 | 0.220 |
Why?
| | Intermediate Filament Proteins | 1 | 2004 | 58 | 0.220 |
Why?
| | Female | 25 | 2025 | 75943 | 0.220 |
Why?
| | Mice, Inbred C57BL | 7 | 2017 | 5909 | 0.220 |
Why?
| | Amyloidogenic Proteins | 1 | 2024 | 16 | 0.210 |
Why?
| | Genotype | 7 | 2017 | 1866 | 0.210 |
Why?
| | Cell Death | 1 | 2025 | 387 | 0.210 |
Why?
| | Biomarkers | 4 | 2025 | 4190 | 0.210 |
Why?
| | Reproducibility of Results | 5 | 2010 | 3356 | 0.210 |
Why?
| | Muscles | 2 | 2017 | 333 | 0.200 |
Why?
| | Analysis of Variance | 4 | 2010 | 1321 | 0.200 |
Why?
| | Algorithms | 2 | 2012 | 1768 | 0.200 |
Why?
| | Cytokines | 4 | 2022 | 2100 | 0.190 |
Why?
| | Peptides | 2 | 2024 | 979 | 0.190 |
Why?
| | Male | 22 | 2025 | 70179 | 0.190 |
Why?
| | Imipramine | 1 | 2022 | 11 | 0.190 |
Why?
| | Cell Culture Techniques | 2 | 2018 | 368 | 0.190 |
Why?
| | Plant Cells | 3 | 2010 | 5 | 0.190 |
Why?
| | Cell Line | 3 | 2017 | 2887 | 0.190 |
Why?
| | Rats | 2 | 2025 | 5637 | 0.190 |
Why?
| | Predictive Value of Tests | 4 | 2011 | 2075 | 0.180 |
Why?
| | Polymerization | 1 | 2022 | 128 | 0.180 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2009 | 855 | 0.180 |
Why?
| | Catalysis | 1 | 2022 | 320 | 0.170 |
Why?
| | Arteritis | 1 | 2021 | 27 | 0.170 |
Why?
| | Cerebral Cortex | 1 | 2004 | 462 | 0.170 |
Why?
| | Interneurons | 1 | 2022 | 124 | 0.170 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2022 | 161 | 0.170 |
Why?
| | Arthritis, Rheumatoid | 1 | 2010 | 1178 | 0.170 |
Why?
| | Chemical Precipitation | 1 | 2020 | 39 | 0.170 |
Why?
| | Healthy Aging | 1 | 2021 | 37 | 0.170 |
Why?
| | Protein Aggregation, Pathological | 1 | 2020 | 22 | 0.160 |
Why?
| | Varicella Zoster Virus Infection | 1 | 2020 | 24 | 0.160 |
Why?
| | Herpesvirus 3, Human | 2 | 2021 | 336 | 0.160 |
Why?
| | Homozygote | 2 | 2017 | 201 | 0.160 |
Why?
| | Plaque, Amyloid | 3 | 2011 | 19 | 0.160 |
Why?
| | Early Diagnosis | 2 | 2011 | 244 | 0.160 |
Why?
| | Skin | 2 | 2017 | 765 | 0.150 |
Why?
| | Gene Dosage | 2 | 2017 | 142 | 0.150 |
Why?
| | Microglia | 2 | 2023 | 255 | 0.150 |
Why?
| | Neurites | 2 | 2023 | 51 | 0.150 |
Why?
| | Case-Control Studies | 6 | 2020 | 3597 | 0.150 |
Why?
| | Middle Aged | 11 | 2025 | 34647 | 0.150 |
Why?
| | Brain Mapping | 2 | 2012 | 532 | 0.150 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2025 | 2135 | 0.140 |
Why?
| | Immunity | 1 | 2019 | 140 | 0.140 |
Why?
| | Epitope Mapping | 2 | 2008 | 61 | 0.140 |
Why?
| | Gene Knock-In Techniques | 1 | 2018 | 59 | 0.140 |
Why?
| | Thiones | 2 | 2016 | 14 | 0.140 |
Why?
| | Blotting, Western | 3 | 2011 | 1234 | 0.140 |
Why?
| | Phospholipase C gamma | 1 | 2017 | 28 | 0.130 |
Why?
| | Glycogen Synthase Kinase 3 | 2 | 2009 | 82 | 0.130 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 117 | 0.130 |
Why?
| | Phosphodiesterase Inhibitors | 2 | 2009 | 76 | 0.130 |
Why?
| | Calcium | 2 | 2014 | 1192 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 276 | 0.130 |
Why?
| | Heterozygote | 1 | 2017 | 308 | 0.130 |
Why?
| | Attention | 1 | 2020 | 455 | 0.120 |
Why?
| | Transgenes | 1 | 2017 | 186 | 0.120 |
Why?
| | Lithium Chloride | 1 | 2016 | 12 | 0.120 |
Why?
| | Adult | 5 | 2025 | 39391 | 0.120 |
Why?
| | Mammals | 2 | 2011 | 287 | 0.120 |
Why?
| | Receptors, Immunologic | 1 | 2017 | 215 | 0.120 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2016 | 42 | 0.120 |
Why?
| | Neuroimaging | 2 | 2023 | 281 | 0.120 |
Why?
| | Child, Preschool | 2 | 2025 | 11512 | 0.120 |
Why?
| | Long-Term Potentiation | 2 | 2016 | 200 | 0.120 |
Why?
| | Mosaicism | 1 | 2016 | 74 | 0.120 |
Why?
| | Dendritic Spines | 1 | 2016 | 68 | 0.110 |
Why?
| | Mice, Inbred BALB C | 2 | 2008 | 1275 | 0.110 |
Why?
| | Executive Function | 1 | 2020 | 460 | 0.110 |
Why?
| | Functional Laterality | 3 | 2012 | 242 | 0.110 |
Why?
| | Membrane Glycoproteins | 1 | 2017 | 502 | 0.110 |
Why?
| | Recombinant Proteins | 2 | 2023 | 1363 | 0.110 |
Why?
| | PC12 Cells | 1 | 2014 | 40 | 0.110 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2017 | 439 | 0.110 |
Why?
| | Lipids | 1 | 2019 | 690 | 0.110 |
Why?
| | Nerve Growth Factor | 1 | 2014 | 34 | 0.110 |
Why?
| | Microscopy, Electron | 1 | 2014 | 441 | 0.110 |
Why?
| | Pyrimidines | 2 | 2016 | 512 | 0.100 |
Why?
| | Young Adult | 2 | 2025 | 13749 | 0.100 |
Why?
| | Amnesia | 2 | 2012 | 46 | 0.100 |
Why?
| | History, 21st Century | 1 | 2014 | 220 | 0.100 |
Why?
| | Membrane Fluidity | 1 | 2013 | 8 | 0.100 |
Why?
| | Immunohistochemistry | 4 | 2011 | 1739 | 0.100 |
Why?
| | History, 20th Century | 1 | 2014 | 330 | 0.100 |
Why?
| | Pancreatitis, Alcoholic | 1 | 2012 | 2 | 0.100 |
Why?
| | Trypsinogen | 1 | 2012 | 11 | 0.100 |
Why?
| | Risk Factors | 6 | 2014 | 10482 | 0.100 |
Why?
| | Claudins | 1 | 2012 | 24 | 0.100 |
Why?
| | Trypsin | 1 | 2012 | 76 | 0.100 |
Why?
| | Cell Cycle | 1 | 2016 | 600 | 0.100 |
Why?
| | Anxiety | 1 | 2020 | 1090 | 0.100 |
Why?
| | Memory Disorders | 2 | 2012 | 182 | 0.090 |
Why?
| | Enzyme Inhibitors | 1 | 2016 | 855 | 0.090 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 228 | 0.090 |
Why?
| | Brain Chemistry | 1 | 2012 | 117 | 0.090 |
Why?
| | Neuroglia | 1 | 2013 | 173 | 0.090 |
Why?
| | Glutamic Acid | 1 | 2014 | 256 | 0.090 |
Why?
| | Centrosome | 1 | 2011 | 71 | 0.090 |
Why?
| | Parkinsonian Disorders | 1 | 2011 | 43 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1656 | 0.090 |
Why?
| | Follow-Up Studies | 2 | 2011 | 5212 | 0.090 |
Why?
| | Entorhinal Cortex | 1 | 2011 | 15 | 0.090 |
Why?
| | Xenopus | 1 | 2011 | 89 | 0.090 |
Why?
| | Age Factors | 2 | 2009 | 3294 | 0.090 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2013 | 260 | 0.090 |
Why?
| | Immunity, Innate | 1 | 2017 | 852 | 0.090 |
Why?
| | Neuronal Plasticity | 1 | 2014 | 305 | 0.090 |
Why?
| | Longitudinal Studies | 4 | 2012 | 2938 | 0.090 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 420 | 0.080 |
Why?
| | Vaccines, DNA | 1 | 2010 | 32 | 0.080 |
Why?
| | Mice, Knockout | 2 | 2010 | 3071 | 0.080 |
Why?
| | Inflammation | 1 | 2022 | 2902 | 0.080 |
Why?
| | Child | 2 | 2025 | 22414 | 0.080 |
Why?
| | Oocytes | 1 | 2011 | 179 | 0.080 |
Why?
| | Macrophage Colony-Stimulating Factor | 1 | 2010 | 21 | 0.080 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2010 | 89 | 0.080 |
Why?
| | Serine Proteinase Inhibitors | 1 | 2009 | 48 | 0.080 |
Why?
| | Florida | 1 | 2009 | 116 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 2009 | 44 | 0.070 |
Why?
| | Microdialysis | 1 | 2009 | 54 | 0.070 |
Why?
| | Homeostasis | 1 | 2013 | 636 | 0.070 |
Why?
| | Observer Variation | 1 | 2010 | 357 | 0.070 |
Why?
| | Theophylline | 1 | 2009 | 43 | 0.070 |
Why?
| | Cell Line, Transformed | 1 | 2009 | 145 | 0.070 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2009 | 311 | 0.070 |
Why?
| | Geriatric Assessment | 1 | 2010 | 226 | 0.070 |
Why?
| | Drug Synergism | 1 | 2009 | 375 | 0.070 |
Why?
| | Tubulin | 1 | 2010 | 146 | 0.070 |
Why?
| | Ethanol | 1 | 2013 | 629 | 0.070 |
Why?
| | Genetic Therapy | 1 | 2010 | 315 | 0.070 |
Why?
| | Psychomotor Performance | 2 | 2009 | 329 | 0.070 |
Why?
| | Antibody Specificity | 1 | 2008 | 187 | 0.070 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2009 | 129 | 0.070 |
Why?
| | Drug Interactions | 1 | 2009 | 406 | 0.070 |
Why?
| | Cross Reactions | 1 | 2008 | 133 | 0.070 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2009 | 274 | 0.070 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 987 | 0.070 |
Why?
| | Fibroblasts | 1 | 2013 | 1021 | 0.070 |
Why?
| | Time Factors | 2 | 2009 | 6966 | 0.070 |
Why?
| | Cell Cycle Proteins | 1 | 2011 | 632 | 0.070 |
Why?
| | Genetic Variation | 1 | 2012 | 1000 | 0.070 |
Why?
| | Blood | 1 | 2007 | 113 | 0.070 |
Why?
| | Exploratory Behavior | 1 | 2007 | 91 | 0.070 |
Why?
| | Antibody Formation | 1 | 2008 | 298 | 0.060 |
Why?
| | t-Complex Genome Region | 1 | 2006 | 3 | 0.060 |
Why?
| | Drug Administration Schedule | 1 | 2009 | 771 | 0.060 |
Why?
| | Bone Marrow | 1 | 2008 | 302 | 0.060 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2007 | 98 | 0.060 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2006 | 93 | 0.060 |
Why?
| | Up-Regulation | 1 | 2010 | 860 | 0.060 |
Why?
| | Supranuclear Palsy, Progressive | 1 | 2006 | 18 | 0.060 |
Why?
| | Rolipram | 1 | 2006 | 3 | 0.060 |
Why?
| | In Situ Nick-End Labeling | 1 | 2006 | 126 | 0.060 |
Why?
| | Silver Staining | 1 | 2006 | 17 | 0.060 |
Why?
| | Valine | 1 | 2006 | 77 | 0.060 |
Why?
| | Phosphorylation | 2 | 2011 | 1774 | 0.060 |
Why?
| | Problem Solving | 1 | 2007 | 156 | 0.060 |
Why?
| | Adolescent | 1 | 2025 | 22130 | 0.060 |
Why?
| | Methionine | 1 | 2006 | 159 | 0.060 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 175 | 0.060 |
Why?
| | Retrospective Studies | 2 | 2022 | 16374 | 0.060 |
Why?
| | Behavior, Animal | 2 | 2006 | 516 | 0.060 |
Why?
| | Immunologic Memory | 1 | 2008 | 360 | 0.060 |
Why?
| | Superoxide Dismutase | 1 | 2007 | 352 | 0.060 |
Why?
| | Severity of Illness Index | 2 | 2011 | 2903 | 0.060 |
Why?
| | Spinal Cord | 1 | 2007 | 376 | 0.060 |
Why?
| | Spleen | 1 | 2006 | 525 | 0.060 |
Why?
| | Benzothiazoles | 1 | 2004 | 41 | 0.050 |
Why?
| | Genetics, Behavioral | 1 | 2004 | 34 | 0.050 |
Why?
| | Lysine | 1 | 2006 | 292 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 2064 | 0.050 |
Why?
| | Flow Cytometry | 1 | 2008 | 1197 | 0.050 |
Why?
| | Thiazoles | 1 | 2004 | 134 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2006 | 761 | 0.050 |
Why?
| | Gene Frequency | 2 | 2017 | 494 | 0.050 |
Why?
| | Immunoglobulin G | 1 | 2008 | 900 | 0.050 |
Why?
| | Memory, Short-Term | 1 | 2006 | 267 | 0.050 |
Why?
| | Indicators and Reagents | 1 | 2003 | 110 | 0.050 |
Why?
| | Biological Specimen Banks | 1 | 2024 | 99 | 0.050 |
Why?
| | Diffusion Tensor Imaging | 1 | 2023 | 78 | 0.050 |
Why?
| | Europe | 1 | 2024 | 411 | 0.050 |
Why?
| | West Nile virus | 1 | 2023 | 42 | 0.050 |
Why?
| | Growth Disorders | 1 | 2022 | 87 | 0.050 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2022 | 68 | 0.050 |
Why?
| | Caspase 3 | 1 | 2023 | 250 | 0.050 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2023 | 156 | 0.050 |
Why?
| | RNA, Messenger | 1 | 2010 | 2828 | 0.050 |
Why?
| | Nuclear Proteins | 1 | 2006 | 719 | 0.040 |
Why?
| | Prognosis | 1 | 2010 | 4080 | 0.040 |
Why?
| | Models, Biological | 1 | 2009 | 1828 | 0.040 |
Why?
| | Pregnancy | 1 | 2014 | 7092 | 0.040 |
Why?
| | Viral Load | 1 | 2023 | 506 | 0.040 |
Why?
| | DNA, Complementary | 1 | 2021 | 274 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 325 | 0.040 |
Why?
| | United States | 2 | 2015 | 15310 | 0.040 |
Why?
| | Intracellular Space | 1 | 2020 | 68 | 0.040 |
Why?
| | Acyclovir | 1 | 2020 | 95 | 0.040 |
Why?
| | Extracellular Space | 1 | 2020 | 129 | 0.040 |
Why?
| | Protein Aggregates | 1 | 2020 | 78 | 0.040 |
Why?
| | Viral Envelope Proteins | 1 | 2020 | 97 | 0.040 |
Why?
| | T-Lymphocytes | 1 | 2008 | 2007 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2009 | 5697 | 0.030 |
Why?
| | Cell Membrane | 1 | 2001 | 724 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 1 | 2022 | 556 | 0.030 |
Why?
| | Protein Interaction Maps | 1 | 2017 | 49 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2012 | 774 | 0.030 |
Why?
| | Haplotypes | 1 | 2019 | 499 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2010 | 5974 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 372 | 0.030 |
Why?
| | Linkage Disequilibrium | 1 | 2017 | 255 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2006 | 2608 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2017 | 391 | 0.030 |
Why?
| | Discriminant Analysis | 2 | 2007 | 37 | 0.030 |
Why?
| | Exome | 1 | 2017 | 238 | 0.030 |
Why?
| | Genetic Testing | 1 | 2019 | 463 | 0.030 |
Why?
| | Long-Term Synaptic Depression | 1 | 2016 | 55 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2019 | 528 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2023 | 2506 | 0.030 |
Why?
| | Sweden | 1 | 2015 | 104 | 0.030 |
Why?
| | Protective Factors | 1 | 2015 | 96 | 0.030 |
Why?
| | Odds Ratio | 1 | 2017 | 1057 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2016 | 1094 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2020 | 747 | 0.030 |
Why?
| | Drug Discovery | 1 | 2014 | 147 | 0.030 |
Why?
| | Pedigree | 1 | 2015 | 511 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2017 | 2158 | 0.020 |
Why?
| | Congresses as Topic | 1 | 2014 | 230 | 0.020 |
Why?
| | Age of Onset | 1 | 2014 | 534 | 0.020 |
Why?
| | Kinetics | 1 | 2016 | 1655 | 0.020 |
Why?
| | Stroke | 1 | 2021 | 1158 | 0.020 |
Why?
| | Autopsy | 1 | 2012 | 98 | 0.020 |
Why?
| | Threonine | 1 | 2011 | 47 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2011 | 154 | 0.020 |
Why?
| | Motor Activity | 2 | 2007 | 720 | 0.020 |
Why?
| | Reference Values | 1 | 2012 | 807 | 0.020 |
Why?
| | ROC Curve | 1 | 2012 | 590 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2011 | 302 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1771 | 0.020 |
Why?
| | Linear Models | 1 | 2012 | 858 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2014 | 1057 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 627 | 0.020 |
Why?
| | Alleles | 1 | 2012 | 891 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2011 | 464 | 0.020 |
Why?
| | Superoxide Dismutase-1 | 1 | 2007 | 12 | 0.020 |
Why?
| | Mice, Neurologic Mutants | 1 | 2007 | 21 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2011 | 1502 | 0.020 |
Why?
| | Sex Factors | 1 | 2012 | 2063 | 0.020 |
Why?
| | Random Allocation | 1 | 2007 | 367 | 0.020 |
Why?
| | Corticosterone | 1 | 2007 | 242 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2007 | 324 | 0.010 |
Why?
| | Social Environment | 1 | 2007 | 295 | 0.010 |
Why?
| | RNA | 1 | 2012 | 930 | 0.010 |
Why?
| | Motor Neurons | 1 | 2007 | 234 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2007 | 1249 | 0.010 |
Why?
| | Avoidance Learning | 1 | 2004 | 74 | 0.010 |
Why?
| | Space Perception | 1 | 2004 | 86 | 0.010 |
Why?
| | Factor Analysis, Statistical | 1 | 2004 | 296 | 0.010 |
Why?
| | Synapses | 1 | 2007 | 429 | 0.010 |
Why?
| | Data Interpretation, Statistical | 1 | 2004 | 377 | 0.010 |
Why?
| | Prospective Studies | 1 | 2014 | 7777 | 0.010 |
Why?
| | Regression Analysis | 1 | 2004 | 1023 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2012 | 2096 | 0.010 |
Why?
|
|
Potter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|